• 1
    Romagnani S. The role of lymphocytes in allergic disease. J Allergy Clin Immunol 2000; 105: 399408.
  • 2
    Larché M, Robinson DS, Kay AB. The role of T lymphocytes in the pathogenesis of asthma. J Allergy Clin Immunol 2003; 111: 45064.
  • 3
    Sperger JM, Paller AS. Atopic dermatitis and the atopic march. J Allergy Clin Immunol 2003; 112: s11827.
  • 4
    Strachan DP. Hay fever, hygiene and household size. Br Med J 1989; 299: 125960.
  • 5
    Matricardi PM, Rosmini F, Riondino S et al. Exposure to foodborne and orofecal microbes versus airborne viruses in relation to atopy and allergic asthma: an epidemiological study. Br Med J 2000; 320: 4127.
  • 6
    Alm JS, Swartz J, Lilja G et al. Atopy in children with an anthroposophic style of life. Lancet 1999; 353: 14848.
  • 7
    Braun-Fahrlander C, Riedler J, Herz U et al. Environmental exposure to endotoxin and its relation to asthma in school-age children. New Engl J Med 2002; 347: 86977.
  • 8
    Romagnani S. Regulation of Th2 development in allergy. Curr Opin Immunol 1994; 6: 83846.
  • 9
    Martinez FD. The coming-of-age of the hygiene hypothesis. Respir Res 2001; 2: 12932.
  • 10
    Yazdanbakhah M, Kremsner PG, Van Ree R. Allergy, parasites, and the hygiene hypothesis. Science 2002; 296: 4904.
  • 11
    Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. New Engl J Med 2002; 347: 91120.
  • 12
    Wills-Karp M, Santeliz J , Karp CL. The germless allergic disease: revisiting the hygiene hypothesis. Nature Rev Immunol 2001; 1: 6975.
  • 13
    Sabroe I, Read RC, Whyte MKB et al. Toll-like receptors in health and disease: complex questions remain. J Immunol 2003; 74: 16305.
  • 14
    Manetti R, Parronchi P, Giudizi MG et al. Natural killer cell stimulatory factor (interleukin-12) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J Exp Med 1993; 177: 1199204.
  • 15
    Kaplan MH, Sun YL, Hoey T et al. Impaired IL-12 responses and enhanced development of Th2 cells in STAT-4-deficient mice. Science 1996; 382: 1747.
  • 16
    Szabo SJ, Kim ST, Costa GL et al. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 2000; 100: 65569.
  • 17
    Maggi E, Parronchi P, Manetti R et al. Reciprocal regulatory role of IFN-γ and IL-4 on the in vitro development of human Th1 and Th2 cells. J Immunol 1992; 148: 21427.
  • 18
    Parronchi P, De Carli M, Manetti R et al. IL-4 and IFN (s) (alpha and gamma) exhibit opposite regulatory effects on the development of cytolytic potential by TH1 or TH2 human T cell clones. J Immunol 1992; 149: 297782.
  • 19
    Rengarajan J, Szabo SJ, Glimcher LH. Transcriptional regulation of Th1/Th2 polarization. Immunol Today 2000; 21: 47983.
  • 20
    Agrawal S, Agrawal A, Doughty B et al. Different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase mitogen-activated protein kinase and c-Fos. J Immunol 2003; 171: 49849.
  • 21
    Redecke V, Hacker H, Datta SK et al. Activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma. J Immunol 2004; 172: 272943.
  • 22
    Eisenbarth SC, Piggott DA, Huleatt JW, Visintin I, Herrick C, Bottomly K. Lipolysaccharide-enhanced, Toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J Exp Med 2002; 196: 164551.
  • 23
    Romagnani S. Lymphokine production by human T cells in disease states. Annu Rev Immunol 1994; 12: 22757.
  • 24
    Abbas AK, Murphy K, Sher A. Functional diversity of helper T lymphocytes. Nature 1996; 383: 78793.
  • 25
    Suri-Payer E, Amar AZ, Thornton AM et al. CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J Immunol 1998; 160: 12128.
  • 26
    Weiner HL. Induction and mechanism of action of transforming growth factor beta-secreting Th3 regulatory cells. Immunol Rev 2001; 182: 20714.
  • 27
    Roncarolo MG, Bacchetta R, Bordignon C et al. Type 1 T regulatory cells. Immunol Rev 2001; 182: 6879.
  • 28
    Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.Nat Immunol 2003; 4: 3306.
  • 29
    McHugh RS, Whitters MJ, Piccirillo CA, Young DA, Shevach EM, Collins M, Byrne MC. CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 2002; 6: 31123.
  • 30
    Bluestone JA, Abbas AK. Natural versus adaptive regulatory T cells. Nature Rev Immunol 2003; 3: 2537.
  • 31
    Netea MG, Sutmuller R, Hermann C et al. Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells. J Immunol 2004; 172: 37128.
  • 32
    Platts-Mills T, Vaughan J, Squillace S et al. Sensitization, asthma and a modified Th2 response in children exposed to cat allergen: a population based cross-sectional study. Lancet 2001; 357: 7526.
  • 33
    Holt PG, Macaubas C, Strumbles PA, Sly PD. The role of allergy in the development of asthma. Nature 1999; 402 (6760 Suppl): 127.
  • 34
    Lynch NR, Lopez RI, DiPrisco-Fuenmayor MC, Hagel I, Medouze L, Viana G, Ortega C, Prato G. Allergic reactivity and socioeconomic level in a tropical environment. Clin Allergy 1987; 17: 199207.
  • 35
    Pugliatti M, Sotgiu S, Solinas G et al. Multiple sclerosis epidemiology in Sardinia: evidence for a true increasing risk. Acta Neurol Scand 2001; 103: 206.
  • 36
    Stefano S, Maura P, Alessandra S et al. Does the ‘hygiene hypothesis’ provide an explanation for the high prevelence of multiple sclerosis in Sardinia? Autoimmunity 2003; 36: 25760.
  • 37
    Cook SD, Cromarty JI, Tapp W et al. Declining incidence of multiple sclerosis in the Orkney Islands. Neurology 1985; 35: 54551.
  • 38
    Farrokyar F, Swarbrick ET, Levine EJ. A critical review of epidemiological studies in inflammatory bowel disease. Scan J Gastroenterol 2001; 36: 215.
  • 39
    Sewell DL, Reinke EK, Logan LH et al. Immunoregulation of CNS autoimmunity by helminth and mycobacterial infections. Immunol Lett 2002; 82: 10110.
  • 40
    Hilliquin P, Allanore Y, Coste J et al. Reduced incidence and prevalence of atopy in rheumatoid arthritis. Results of a case-control study. Rheumatology 2000; 39: 10206.
  • 41
    Van Roon JAG, Bijlsma JWJ. Th2 mediated regulation in RA and spondyloarthropathies. Ann Rheum Dis 2002; 61: 9514.
  • 42
    Oro AM, Guarino TJ, Driver R et al. Regulation of disease susceptibility: decreased prevalence of IgE-mediated disease in patients with multiple sclerosis. J Allergy Clin Immunol 1996; 97: 14028.
  • 43
    Tremlett HL, Evans J, Wiles CM et al. Asthma and multiple sclerosis: an inverse association in a case-control general practice population. QJM 2002; 95: 7536.
  • 44
    Tang L, Benjaponpitak S, DeKruyff RH et al. Reduced prevalence of allergic disease with multiple sclerosis is associated with enhanced IL-12 production. J Allergy Clin Immunol 1998; 102: 42835.
  • 45
    Johnson RJ, Hurtado A, Merszei J et al. Hypothesis: dysregulation of immunologic balance resulting from hygiene and socioeconomic factors may influence the epidemiology and cause of glomerulonephritis worldwide. Am J Kidney Dis 2003; 42: 57581.
  • 46
    Manetti R, Annunziato F, Tomasevic L et al. Polyinosinic acid: polycytidylic acid promotes T helper type 1-specific immune responses by stimulating macrophage production of interferon-alpha and interleukin-12. Eur J Immunol 1999; 25: 265660.
  • 47
    Koski GK, Kariko K, Xu S et al. Innate immunity system discriminates between RNA containing bacterial versus eukaryotic structural features that prime for high-level IL-12 secretion by dendritic cells. J Immunol 2004; 172: 398993.
  • 48
    Parronchi P, Brugnolo F, Annunziato F et al. Phosphorothioate oligodeoxynucletides promote the in vitro development of human allergen-specific CD4+ T cells into Th1 effectors. J Immunol 1999; 163: 594653.
  • 49
    Tighe H, Takabayashi K, Schwartw D et al. Conjugation of immunostimulatory DNA to the short ragweed allergen amb a 1 enhances its immunogenicity and reduces its allergenicity. J Allergy Clin Immunol 2000; 106: 12434.
  • 50
    Annunziato F, Cosmi L, Manetti R et al. Reversal of human allergen-specific CRTH2+ Th2 cells by IL-12 or the PS-DSP30 oligodeoxynucleotide. J Allergy Clin Immunol 2001; 108: 81521.
  • 51
    Brugnolo F, Sampognaro S, Fintoni T et al. The novel synthetic immune response modifier R-848 (Resiquimod) has a powerful effect on the in vitro switching of human allergen-specific CD4+ Th2 lymphocytes into IFN-γ-producing cells. J Allergy Clin Immunol 2003; 111: 3808.
  • 52
    Tournoy KG, Kips JC, Pauwels RA. Is Th1 the solution for Th2 in asthma? Clin Exp Allergy 2002; 31: 1729.
  • 53
    Lack G, Bradley KL, Hamelmann E et al. Nebulized but not parenteral IFN-gamma decreases IgE production and normalizes airway function in a murine model of allergen sensitization. J Immunol 1994; 152: 254654.
  • 54
    Lack G, Bradley KL, Hamelmann E et al. Nebulized IFN-gamma inhibits the development of secondary allergen responses in mice. J Immunol 1996; 157: 14329.
  • 55
    Dow SW, Schwartze J, Heath TD et al. Systemic and local interferon gamma gene delivery to the lungs for treatment of allergen-induced airway hyperresponsiveness in mice. Hum Gene Ther 1999; 10: 190514.
  • 56
    Li XM, Chopra RK, Chou TY et al. Mucosal IFN-gamma gene transfer inhibits pulmonary allergic responses in mice. J Immunol 1996; 157: 32169.
  • 57
    Martin RJ, Boguniewicz M, Henson JE et al. The effects of inhaled interferon-gamma in normal human airways. Am Rev Respir Dis 1993; 148: 167782.
  • 58
    Boguniewicz M, Martin RJ, Martin D et al. The effects of nebulized interferon-gamma in asthmatic airways. J Allergy Clin Immunol 1995; 95: 1335.
  • 59
    Randolph DA, Carruthers CJL, Szabo SJ et al. Modulation of airway inflammation by passive transfer of allergen-specific Th1 and Th2 cells in a mouse model of asthma. J Immunol 1999; 162: 137583.
  • 60
    Hansen G, Berry G, DeKruyff RH et al. Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation. J Clin Invest 1999; 103: 17583.
  • 61
    Kips JC, Brusselle GJ, Joos JF et al. Interleukin-12 inhibits antigen-induced airway hyperresponsiveness in mice. Am J Respir Crit Care Med 1996; 153: 5359.
  • 62
    Gerhold K, Blumchen K, Bock A et al. Endotoxins prevent murine IgE production, Th2 immune responses and development of airway eosinophilia but not airway hyperreactivity. J Allergy Clin Immunol 2002; 110: 1106.
  • 63
    Walter DM, Womg CP, DeKruyff RH et al. IL-18 gene transfer by adenovius prevents the development of and reverses established allergen-induced airway hyperreactivity. J Immunol 2001; 166: 63928.
  • 64
    Sugimoto T, Ishikawa Y, Yoshimoto T et al. Interleukin 18 acts on memory T helper cells type 1 to induce airway inflammation and hyperresponsiveness in a naïve host mouse. J Exp Med 2004; 199: 53545.
  • 65
    Klinman DM. Immunotherapeutic uses of CpG oligodeoxynucleotides. Nature Rev Immunol 2004; 4: 110.
  • 66
    Erb KJ, Holloway JW, Sobeck A et al. Infection of mice with Mycobacterium bovis-Bacillus Calmette Guerin (BCG) suppresses allergen-induced airway eosinophilia. J Exp Med 1998; 187: 5619.
  • 67
    Major T, Wohlleben G, Reibetanz B et al. Application of heat killed Mycobacterium bovis-BCG into the lungs inhibits the development of allergen-induced Th2 response. Vaccine 2002; 20: 153240.
  • 68
    Tsai JJ, Liu YH, Shen HD et al. Prevention of Der p2-induced airway inflammation by Mycobacterium-bacillus Calmette Guerin. J Microbiol Immunol Infect 2002; 35: 1528.
  • 69
    Shirikawa T, Enomoto T, Shimazu S et al. The inverse association between tuberculin responses and atopic disorders. Science 1997; 275: 779.
  • 70
    Marks GB, Ng K, Zhou J et al. The effect of neonatal BCG vaccination on atopy and asthma at age 7–14 years: an historical cohort study in a community with a very low prevalence of tuberculosis infection and a high prevalence of atopic disease. J Allergy Clin Immunol 2003; 111: 5419.
  • 71
    Townley RG, Barna IB, Patino C et al. The effect of BCG vaccine at birth on the development of atopy or allergic disease in young children. Ann Allergy Asthma Immunol 2004; 92: 3505.
  • 72
    Pochard P, Gosset P, Grangette C et al. Lactic acid bacteria inhibit TH2 cytokine production by mononuclear cells from allergic patients. J Allergy Clin Immunol 2002; 110: 61723.
  • 73
    Culley FJ, Pollot J, Openshaw PJM. Age at first viral infection determines the pattern of T cell-mediated disease during reinfection in adulthood. J Exp Med 2002; 196: 13816.
  • 74
    Wollheben G, Muller J, Tatsch U et al. Influenza A virus infection inhibits the efficient recruitment of Th2 cells into the airways and the development of airway eosinophilia. J Immunol 2003; 170: 460111.
  • 75
    Dahl ME, Dabbagh K, Liggitt D et al. Viral induced T helper type 1 responses enhance allergic disease by effects on lung dendritic cells. Nat Immunol 2004; 5: 33743.
  • 76
    Mardsland BJ, Harris NL, Camberis M et al. Bystander suppression of allergic airway inflammation by lung resident memory CD8+ T cells. Proc Natl Acad Sci USA 2004; 101: 611621.
  • 77
    Smart JM, Horak E, Kemp AS et al. Polyclonal and allergen-induced cytokine responses in adults with asthma: resolution of asthma is associated with normalization of IFN-γ responses. J Allergy Clin Immunol 2002; 110: 4506.
  • 78
    Shahid SK, Kharltonov SA, Wilson NM et al. Increased interleukin-4 and decreased IFN-γ in exhaled breath condensate of children with asthma. Am J Respir Crit Care Med 2002; 165: 12903.
  • 79
    Wierenga EA, Snoek M, Jansen HM et al. Functional subsets of allergen-reactive human CD4+ T cells. Immunol Today 1991; 12: 3925.
  • 80
    Romagnani S. Immunologic influences on allergy and the TH1/TH2 balance. J Allergy Clin Immunol 2004; 113: 395400.
  • 81
    Turcanu V, Maleki SJ, Lack G. Characterization of lymphocyte responses to peanuts in normal children, peanut-allergic children, and allergic children who acquired tolerance to peanuts. J Clin Invest 2003; 111: 106572.
  • 82
    Gangur V, Simons ER, Hayglass KT. Human IP-10 selectively promotes dominance of polyclonally activated and environmental antigen-driven IFN-γ over IL-4 responses. FASEB J 1998; 12: 70513.
  • 83
    Campbell JD, Gangur V, Simons FER et al. Allergic humans are hyporesponsive to a CXCR3 ligand-mediated Th1 immunity-promoting loop. FASEB J 2004; 18: 32931.
  • 84
    Prescott SL, Taylor A, King B et al. Neonatal interleukin-12 capacity is associated with variations in allergen-specific immune responses in the neonatal and postnatal periods. Clin Exp Allergy 2003; 33: 56672.
  • 85
    Reider N, Reider D, Ebner S. Dendritic cells contribute to the development of atopy by an insufficiency in IL-12 production. J Allergy Clin Immunol 2002; 109: 8995.
  • 86
    Hamid QA, Shotman E, Jacobson MR et al. Increases in IL-12 messenger RNA+ cells accompany inhibition of allergen-induced late skin responses after successful grass pollen immunotherapy. J Allergy Clin Immunol 1997; 99: 25460.
  • 87
    Nakamura Y, Ghaffar O, Olivenstein R et al. Gene expression of the GATA-3 transcription factor is increased in atopic asthma. J Allergy Clin Immunol 1999; 103: 21522.
  • 88
    Finotto S, Neurath MF, Glickman JM et al. Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet. Science 2002; 295: 3368.
  • 89
    Shapenko A, Leipe J, Niesner U et al. GATA-3 in human T cell helper type 2 development. J Exp Med 2004; 199: 4238.
  • 90
    Renz H, Von Mutius E, Illi S, Wolkers F, Hirsch T, Welland SK. Th1/Th2 immune responses profiles differ between atopic children in eastern and western Germany. J Allergy Clin Immunol 2002; 109: 33842.
  • 91
    Gehring U, Bischoff W, Fahlbusch B et al. House dust endotoxin and allergic sensitization in children. Am J Respir Crit Care Med 2002; 166: 93944.
  • 92
    Lauener RP, Birchler T, Adamaski J et al. Expression of CD14 and Toll-like receptor 2 in farmers' and non-farmers' children. Lancet 2002; 360: 4656.
  • 93
    Gambineri E, Torgerson TR, Ochs HD. Immune dysregulation, poliendocrinopathy, enteropathy, and X-linked inheritance (IPEX) a syndrome of systemic autoimmunity caused by mutations of Foxp3, a critical regulator of T-cell homeostasis. Curr Opin Rheumatol 2003; 15: 4308.
  • 94
    Cosmi L, Lotta F, Lazzeri E et al. Th2 cells are less susceptible than Th1 cells to the suppressive activity of CD25+ regulatory thymocytes because of their responsiveness to different cytokines. Blood 2004; 103: 311721.
  • 95
    Suto A, Nakajima H, Kagami S-I et al. Role of CD4+CD25+ regulatory T cells in T helper 2 cell-mediated allergic inflammation in the airways. Am J Respir Care Med 2001; 164: 6807.
  • 96
    Jaffar Z, Sivakuru T, Roberts K. CD4+CD25+ T cells regulate airway eosinophilic inflammation by modulating the Th2 cell phenotype. J Immunol 2004; 172: 38429.
  • 97
    Tiemessen MM, Van Hoffen E, Knulst AC et al. CD4+CD25+ regulatory T cells are not functionally impaired in adult patients with IgE-mediated cow's milk allergy. J Allergy Clin Immunol 2002; 110: 9346.
  • 98
    Ling EM, Smith T, Nguyen XD et al. Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet 2004; 363: 60815.
  • 99
    Hansen G, McIntire JJ, Yeung VP et al. CD4+ T helper cells engineered to produce latent TGF-beta reverse allergen-induced airway hyperreactivity and inflammation. J Clin Invest 2000; 105: 6170.
  • 100
    Stampfli MR, Cwiartka M, Gajewska BU et al. Interleukin-10 gene transfer to the airways regulates allergic mucosal sensitization in mice. Am J Respir Cell Mol Biol 1999; 21: 58696.
  • 101
    Oh W-J, Seroogy CM, Meyer EH et al. CD4 T-helper cells engineered to produce IL-10 prevent allergen-induced airway hyperreactivity and inflammation. J Allergy Clin Immunol 2002; 110: 4608.
  • 102
    Zuani-Amorim C, Sawicka E, Manlius C et al. Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells. Nature Med 2002; 8: 6259.
  • 103
    Smitt JJ, Van Loveren H, Hoekstra MO et al. Mycobacterium vaccae administration during allergen sensitization or challenge suppresses asthmatic features. Clin Exp Allergy 2003; 33: 10839.
  • 104
    Cottrez F, Hurst SD, Coffman RL et al. T regulatory cells 1 inhibit a Th2-specific response in vivo. J Immunol 2000; 165: 484853.
  • 105
    Blaser K, Akdis CA. Interleukin-10 T regulatory cells and specific allergy treatment. Clin Exp Allergy 2004; 34: 32831.
  • 106
    Jutel M, Akdis M, Budak F et al. IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol 2003; 33: 120514.
  • 107
    Nouri-Aria KT, Wackholz PA, Francis JM et al. Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity. J Immunol 2004; 172: 32529.
  • 108
    Chatelain R, Mauze S, Coffman RL. Experimental Leishmania major infection in mice: role of IL-10. Parasite Immunol 1999; 21: 2118.
  • 109
    Laouini D, Alenius H, Tsitsikov E, Geha RS. IL-10 skews the immune response to Th2 and is critical for skin eosinophilia in a murine model of allergic dermatitis. J Clin Invest 2003; 112: 105866.
  • 110
    Shapenko A, Niedobitek GU, Kalden JR et al. Generation and regulation of human Th1-biased immune responses in vivo: a critical role for IL-4 and IL-10. J Immunol 2004; 172: 642734.